Contemporary Reperfusion Therapy for Cardiogenic Shock: The GUSTO-I Trial Experience
نویسنده
چکیده
ObJectives. This study sought to examine the incidence, temporal profile and clinical implications of shock in a large trial of thrombolytic therapy for acute myocardial infarction. Background. Despite advances in the treatment of acute ischemic syndromes, cardiogenic shock remains associated with significant morbidity and mortality. Methods. Patients who presented within 6 h of symptom onset were randomized to four treatment strategies: 1) streptokinase plus subcutaneous heparin; 2) streptokinase plus intravenous heparin; 3) accelerated recombinant tissue-type plasminogen act ivator (rt-PA) plus intravenous heparin; or 4t streptokinase and rt-PA plus intravenous heparin. The primary end point was 30-day all-cause mortality. Results. Shock occurred in 2,972 patients ~7.2%): 315 (11%) had shock on arrival, and 2,657 (89°/o) developed shock after hospital admission. Reinfarction occurred in 11% of patients who developed shock compared with 3% of patients without shock. The mortality rate was significantly higher in patients who presented with (57%) or developed (55%) shock than in those without shock (3%) (p < 0.001). Shock developed significantly less frequently in patients receiving rt-PA. There were fewer deaths in patients who presented with shock and were treated with streptokinase plus intravenous heparin or who developed shock and were treated with streptokinase plus subcutaneous heparin. Patients who developed shock had a significantly lower 30-day mortality rate if angioplasty was performed. Conclusions. Because cardiogenic shock occurred most often after admission and with recurrent ischemia and reinfarction, recognizing signs of incipient shock may improve outcome. Fewer patients treated with rt-PA developed shock, yet those developing shock had the same high mortality rate as those presenting with shock, regardless of treatment. Only angioplasty was associated with a significantly lower mortality rate. (JAm CoU Cardiol 1995;26:668-74)
منابع مشابه
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.
OBJECTIVES This study characterized clinical factors predictive of cardiogenic shock developing after thrombolytic therapy for acute myocardial infarction (AMI). BACKGROUND Cardiogenic shock remains a common and ominous complication of AMI. By identifying patients at risk of developing shock, preventive measures may be implemented to avert its development. METHODS We analyzed baseline varia...
متن کاملLong-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.
OBJECTIVES This study sought to assess long-term outcome and determine its predictors among 30-day survivors of cardiogenic shock. BACKGROUND Patients with cardiogenic shock have high in-hospital and 30-day mortality, but there are little data about those who survive beyond 30 days. METHODS We analyzed baseline, in-hospital, and survival data from patients in the U.S. with ST-segment elevat...
متن کاملCardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation.
BACKGROUND Cardiogenic shock is usually considered a sequela of ST-segment elevation myocardial infarction. There are limited prospective data on the incidence and significance of shock in non-ST-segment elevation patients. This study assessed the incidence and outcomes of cardiogenic shock developing after enrollment among patients with and without ST-segment elevation in the Global Use of Str...
متن کاملOne-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial.
BACKGROUND Although 30-day survival is increased in patients with acute myocardial infarction complicated by cardiogenic shock who undergo coronary revascularization, the longer-term outcome in such patients and the duration of benefit from revascularization are unknown. METHODS AND RESULTS We analyzed 30-day survivors of acute myocardial infarction in the Global Utilization of Streptokinase ...
متن کاملFeasibility of Early Mechanical Support During Mechanical Reperfusion of Acute Myocardial Infarct Cardiogenic Shock.
Mechanical reperfusion for acute myocardial infarction cardiogenic shock (AMICS) has a class I A indication in both the American and European guidelines (1). Unfortunately, over the past 20 years, little progress has been made in improving outcomes since the pivotal SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) trial was conducted (2). The recent Food and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016